查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1617697

医疗保健分析测试服务市场：按服务、样本类型、最终用户划分 - 全球预测 2025-2030

Healthcare Analytical Testing Services Market by Services (Batch Release Testing Services, Bioanalytical Testing, Clinical Trials Testing), Sample Type (Biological Samples, Chemical Substances), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医疗保健分析实验室服务市值为48.8亿美元，预计到2024年将达到54.1亿美元，复合年增长率为11.34%，到2030年将达到103.6亿美元。

医疗保健分析测试服务包括各种专业测试服务，这些服务对于确保药品、生技药品和医疗设备等医疗保健产品的安全性、有效性和品质至关重要。对这些服务的需求是由严格的法规环境推动的，该环境要求进行彻底的测试和验证，以确保医疗保健产品在进入市场之前符合所需的标准。分析测试服务的应用跨越产品开发的各个阶段，从早期研发到临床试验以及最终商业化。最终用户主要包括製药公司、医疗设备公司、医疗器材製造商和委外研发机构（CRO）。

主要市场统计
基准年[2023] 48.8亿美元
预计年份 [2024] 54.1亿美元
预测年份 [2030] 103.6亿美元
复合年增长率（%） 11.34%

药品和个人化医疗日益复杂，增加了对先进测试方法的需求，这是调查方法市场的主要驱动力。一个值得注意的成长要素是外包分析测试服务的成长趋势，使公司能够专注于其核心能力，同时利用专业服务供应商的专业知识。此外，分析技术的进步以及生物相似药和生技药品的广泛采用也带来了巨大的成长机会。然而，诸如严格的监管合规性、与先进测试技术相关的高成本以及与复杂生技药品测试相关的技术困难等挑战仍然是潜在的成长阻碍因素。

自动化高通量测试平台和用于资料分析的人工智慧（AI）的研发是具有巨大业务成长潜力的途径。随着行业参与者寻求扩大其全球影响力，投资区域设施并利用当地专业知识是一项推荐策略。市场竞争非常激烈，但差异化服务和策略伙伴关係关係是获得竞争优势的途径。探索精准医学和生物标记发现测试方面的创新也是可能的。在分析服务中采用永续的绿色化学可以提供更长期的效益，并吸引具有环保意识的相关人员。

市场动态：针对快速发展的医疗保健分析实验室服务市场揭示的关键市场洞察

医疗保健分析测试服务市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 医疗保健领域对分析测试外包的需求不断增长
    • 生物製药和医疗设备的持续进步
    • 医疗保健领域公共和私人支出的增加
  • 市场限制因素
    • 缺乏熟练的专业人员
  • 市场机会
    • 融合人工智慧、机器学习等尖端技术
    • 快速检测方法和个人化医疗方法的开发
  • 市场挑战
    • 全球严格的监管标准

波特五力：引领医疗分析实验室服务市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解医疗保健分析测试服务市场的外部影响

外部宏观环境因素在塑造医疗分析实验室服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解医疗保健分析测试服务市场的竞争状况

医疗保健分析实验室服务市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵医疗保健分析测试服务市场供应商的绩效评估

FPNV 定位矩阵是评估医疗保健分析实验室服务市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了医疗分析实验室服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对医疗保健分析实验室服务市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医疗保健领域对分析测试外包的需求增加
      • 生物製药和医疗设备的持续进步
      • 医疗保健领域的公共和私人支出增加
    • 抑制因素
      • 高技能专业人才短缺
    • 机会
      • 融合人工智慧、机器学习等先进技术
      • 快速检测方法和个人化医疗方法的开发
    • 任务
      • 全球严格的监管标准
  • 市场区隔分析
    • 服务：医疗保健领域必备的检测服务，确保药品品质和环境安全
    • 最终用户：分析测试在医疗保健和药物开发中的关键作用，确保安全和效率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章医疗保健分析测试服务市场：依服务分类

  • 大量发布测试服务
  • 生物分析测试
  • 临床试验测试
  • 环境监测

第七章按样本类型分類的医疗保健分析测试服务市场

  • 生物样本
  • 化学品

第八章医疗保健分析测试服务市场：依最终用户分类

  • 临床研究组织
  • 医疗设备公司
  • 製药和生物製药公司

第九章美洲医疗保健分析测试服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太医疗保健分析测试服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的医疗保健分析测试服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • LGM Pharma 加强分析测试和製造能力
    • Kindeva Drug Delivery 增强分析服务并扩大药品和医疗设备的全球能力
    • MilliporeSigma 推出 ChemisTwin，彻底改变生命科学领域的品质测试
  • 战略分析和建议

公司名单

  • Almac Group Limited
  • ALS Limited
  • Catalent, Inc.
  • CD Biosciences Inc.
  • Charles River Laboratories, Inc.
  • Element Materials Technology Group Limited
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc. by Tigermed
  • ICON PLC
  • Intertek Group PLC
  • IQVIA, Inc.
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • Merck KGaA
  • Pace Analytical Services, LLC
  • Piramal Pharma Solutions
  • PPD, Inc.
  • Reading Scientific Services Ltd.
  • Sartorius AG
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: MRR-F949FCDE0EC4

The Healthcare Analytical Testing Services Market was valued at USD 4.88 billion in 2023, expected to reach USD 5.41 billion in 2024, and is projected to grow at a CAGR of 11.34%, to USD 10.36 billion by 2030.

Healthcare Analytical Testing Services encompass a range of specialized laboratory services that are essential for ensuring the safety, efficacy, and quality of healthcare products, including pharmaceuticals, biologics, and medical devices. The necessity of these services stems from the stringent regulatory environment that mandates thorough testing and validation to ensure that healthcare products meet the required standards before reaching the market. The application of analytical testing services spans various stages of product development, from early research and development to clinical trials, and ultimately to commercialization. End-users primarily include pharmaceutical and biopharmaceutical companies, medical device manufacturers, and contract research organizations (CROs).

KEY MARKET STATISTICS
Base Year [2023] USD 4.88 billion
Estimated Year [2024] USD 5.41 billion
Forecast Year [2030] USD 10.36 billion
CAGR (%) 11.34%

The market for healthcare analytical testing services is being significantly driven by the increasing complexity of pharmaceutical products and personalized medicine, which necessitate sophisticated testing methodologies. A notable growth driver is the rising trend in outsourcing analytical testing services, which enables companies to focus on their core competencies while leveraging the expertise of specialized service providers. Additionally, advancements in analytical technologies and the increasing adoption of biosimilars and biologics provide substantial growth opportunities. However, challenges such as strict regulatory compliance, high costs associated with advanced testing techniques, and technical difficulties related to complex biologics testing remain potential growth deterrents.

Innovation and research in the development of automated and high-throughput testing platforms, and artificial intelligence (AI) for data analysis are avenues with immense potential for business growth. As industry players look toward expanding their global presence, investment in regional facilities and leveraging local expertise are recommended strategies. Despite the competitive nature of the market, differentiated service offerings and strategic partnerships provide avenues for competitive advantage. Companies could also explore innovation in precision medicine and biomarker discovery testing, as these areas are set to see burgeoning demand. Adopting sustainable and green chemistry practices in analytical services can further yield long-term benefits and appeal to environmentally-conscious stakeholders.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Analytical Testing Services Market

The Healthcare Analytical Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for analytical testing outsourcing in healthcare sector
    • Ongoing advances in biopharmaceuticals and medical devices
    • Rising public and private expenditure in healthcare sector
  • Market Restraints
    • Lack of highly skilled professionals
  • Market Opportunities
    • Integration of advanced technologies including AI and machine learning
    • Development of rapid testing methods and personalized medicine approach
  • Market Challenges
    • Stringent regulatory standards worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Analytical Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Analytical Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Analytical Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Analytical Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Analytical Testing Services Market

A detailed market share analysis in the Healthcare Analytical Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Analytical Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Analytical Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Analytical Testing Services Market

A strategic analysis of the Healthcare Analytical Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Analytical Testing Services Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, ALS Limited, Catalent, Inc., CD Biosciences Inc., Charles River Laboratories, Inc., Element Materials Technology Group Limited, Eurofins Scientific SE, Frontage Laboratories, Inc. by Tigermed, ICON PLC, Intertek Group PLC, IQVIA, Inc., Laboratory Corporation of America Holdings, Medpace, Inc., Merck KGaA, Pace Analytical Services, LLC, Piramal Pharma Solutions, PPD, Inc., Reading Scientific Services Ltd., Sartorius AG, SGS SA, Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Analytical Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Batch Release Testing Services, Bioanalytical Testing, Clinical Trials Testing, and Environmental Monitoring.
  • Based on Sample Type, market is studied across Biological Samples and Chemical Substances.
  • Based on End User, market is studied across Clinical Research Organizations, Medical Device Companies, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for analytical testing outsourcing in healthcare sector
      • 5.1.1.2. Ongoing advances in biopharmaceuticals and medical devices
      • 5.1.1.3. Rising public and private expenditure in healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of highly skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies including AI and machine learning
      • 5.1.3.2. Development of rapid testing methods and personalized medicine approach
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory standards worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Essential Testing Services in Healthcare Sector, Safeguarding Drug Quality and Environmental Safety
    • 5.2.2. End User: Crucial Role of Analytical Testing in Healthcare and Pharmaceutical Development, Ensuring Safety and Efficiency
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Analytical Testing Services Market, by Services

  • 6.1. Introduction
  • 6.2. Batch Release Testing Services
  • 6.3. Bioanalytical Testing
  • 6.4. Clinical Trials Testing
  • 6.5. Environmental Monitoring

7. Healthcare Analytical Testing Services Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Biological Samples
  • 7.3. Chemical Substances

8. Healthcare Analytical Testing Services Market, by End User

  • 8.1. Introduction
  • 8.2. Clinical Research Organizations
  • 8.3. Medical Device Companies
  • 8.4. Pharmaceutical & Biopharmaceutical Companies

9. Americas Healthcare Analytical Testing Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Healthcare Analytical Testing Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Healthcare Analytical Testing Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Enhancing Analytical Testing and Manufacturing Capabilities by LGM Pharma
    • 12.3.2. Kindeva Drug Delivery Bolsters Analytical Services, Enhancing Global Capabilities in Pharmaceutical and Medical Device Sectors
    • 12.3.3. Launch of ChemisTwin by MilliporeSigma, Revolutionizing Quality Testing in Life Sciences
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Almac Group Limited
  • 2. ALS Limited
  • 3. Catalent, Inc.
  • 4. CD Biosciences Inc.
  • 5. Charles River Laboratories, Inc.
  • 6. Element Materials Technology Group Limited
  • 7. Eurofins Scientific SE
  • 8. Frontage Laboratories, Inc. by Tigermed
  • 9. ICON PLC
  • 10. Intertek Group PLC
  • 11. IQVIA, Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. Medpace, Inc.
  • 14. Merck KGaA
  • 15. Pace Analytical Services, LLC
  • 16. Piramal Pharma Solutions
  • 17. PPD, Inc.
  • 18. Reading Scientific Services Ltd.
  • 19. Sartorius AG
  • 20. SGS SA
  • 21. Thermo Fisher Scientific Inc.
  • 22. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BATCH RELEASE TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL TRIALS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHEMICAL SUBSTANCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023